FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:999-1000 September 27, 2001 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: In their report of bone marrow transplantation in a case of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX), Baud et al. (June 7 issue)¹ incorrectly stated that our patient (described in our 1995 report²) had died. On the contrary, he survived, is now 11 years old, and continues to receive treatment with betamethasone and tacrolimus.² The diagnosis of IPEX has been confirmed by sequence analysis of the FOXP3 gene. He has various complications, including renal tubular damage, severe osteoporosis with multiple compression fractures of vertebrae, short stature, hypotonicity, and cataracts, which are probably the result . . . [Full Text of this Article]

References

This article has been cited by other articles:

• (2004). Dermatologic and Immunologic Findings in the Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked Syndrome. Arch Dermatol 140: 466-472  
• Wildin, R S, Smyk-Pearson, S, Filipovich, A H (2002). Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 39: 537-545 [Abstract] [Full Text]